Skip to main content
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.328
-0.044 (-3.21%)
Apr 29, 2026, 3:45 PM CET

Oncopeptides AB Revenue

In the year 2025, Oncopeptides AB had annual revenue of 71.12M SEK with 124.72% growth. Oncopeptides AB had revenue of 18.57M in the quarter ending December 31, 2025, with 87.28% growth.

Revenue
71.12M
Revenue Growth
+124.72%
P/S Ratio
7.63
Revenue / Employee
948.24K
Employees
75
Market Cap
542.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202571.12M39.47M124.72%
Dec 31, 202431.65M-3.57M-10.14%
Dec 31, 202335.22M26.87M321.54%
Dec 31, 20228.36M-109.94M-92.94%
Dec 31, 2021118.30M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FluoGuide 318.79K
Intervacc AB 20.09M
Corline Biomedical AB 8.59M
Infant Bacterial Therapeutics AB -1.00K
Sprint Bioscience AB 167.39M
Bio-Works Technologies AB 63.11M
Mendus AB -1.44M
Cantargia AB 316.70M
Revenue Rankings

Oncopeptides AB News

More News